Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function

July 26, 2024

https://www.globenewswire.com/news-release/2024/07/25/2918805/0/en/Inozyme-Pharma-Publishes-Preclinical-Data-Supporting-INZ-701-as-a-Potential-Therapy-for-a-Broad-Range-of-Serious-Rare-Diseases-Impacting-Bone-Health-and-Blood-Vessel-Function.html

– Treatment with INZ-701 shown to prevent intimal proliferation in both ENPP1-deficient and wild-type mice, supporting its potential therapeutic application beyond traditional ERT –

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.